Faculty: Wendy Simmons, PA-C, DFAAPA
Carolina Arthritis Associates
Wilmington, North Carolina
Speakers Bureau: Abbvie, Amgen, Boehringer Ingelheim, Pfizer, Radius, UCB
Advisory Board: Agmen, Avion, BMS, Gilead, Janssen, Scipher
Beginning Date: 03/05/21
Ending Date: 03/05/22
TARGET AUDIENCE: Nurse practitioners and physician assistants involved in the management of patients with rheumatic disease.
GOAL STATEMENT: Topic-specific webinars presented by RhAPP faculty members who discuss and review the management of patients with rheumatic disease.
EDUCATIONAL OBJECTIVES: After the completion of this activity, participants should be able to:
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences and Gastroenterology and Hepatology Advanced Practice Providers. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.
This program is accredited for 0.5 contact hours. Program ID #5856.
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 7.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 3/5/2021 to 3/5/2022. AAPA reference number: CME-202252.
Please note, each session is eligible for 0.5 credits.
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is assigned ACPE Universal Program #0797-9999-21-024-H01-P through #0797-9999-21-038-H01-P. This program is designated for up to 7.5 contact hours (0.75 CEUs) of continuing pharmacy education credit. This is a knowledge-based activity.
Please note, this session is assigned ACPE Universal Program #0797-9999-21-025-H01-P.
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All staff at the Annenberg Center for Health Sciences at Eisenhower and Focus Medical Communications have no relationships to disclose.
LEARNER ASSURANCE STATEMENT:
The ACHS is committed to mitigating all conflict of interest issues that could arise as a result of individuals who control activity content and who have relationships with ACCME-defined ineligible companies. The ACHS is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
This program is supported by an educational grant from Gilead Sciences, Inc. and Sanofi Genzyme.